These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34445900)

  • 1. Intensive Comprehensive Aphasia Programmes: a systematic scoping review and analysis using the TIDieR checklist for reporting interventions.
    Monnelly K; Marshall J; Cruice M
    Disabil Rehabil; 2022 Oct; 44(21):6471-6496. PubMed ID: 34445900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in the application of Intensive Comprehensive Aphasia Programs: an international survey of practice.
    Rose ML; Pierce JE; Scharp VL; Off CA; Babbitt EM; Griffin-Musick JR; Cherney LR
    Disabil Rehabil; 2022 Oct; 44(20):5863-5877. PubMed ID: 34251946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communication and quality of life outcomes from an interprofessional intensive, comprehensive, aphasia program (ICAP).
    Hoover EL; Caplan DN; Waters GS; Carney A
    Top Stroke Rehabil; 2017 Mar; 24(2):82-90. PubMed ID: 27456043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Effectiveness of the Queen Square Intensive Comprehensive Aphasia Service for Patients With Poststroke Aphasia.
    Leff AP; Nightingale S; Gooding B; Rutter J; Craven N; Peart M; Dunstan A; Sherman A; Paget A; Duncan M; Davidson J; Kumar N; Farrington-Douglas C; Julien C; Crinion JT
    Stroke; 2021 Oct; 52(10):e594-e598. PubMed ID: 34107735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive comprehensive aphasia programs: an international survey of practice.
    Rose ML; Cherney LR; Worrall LE
    Top Stroke Rehabil; 2013; 20(5):379-87. PubMed ID: 24091280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for pre-school children with co-occurring phonological speech sound disorder and expressive language difficulties: A scoping review.
    Rodgers L; Harding S; Rees R; Clarke MT
    Int J Lang Commun Disord; 2022 Jul; 57(4):700-716. PubMed ID: 35373429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinician perspectives of an intensive comprehensive aphasia program.
    Babbitt EM; Worrall LE; Cherney LR
    Top Stroke Rehabil; 2013; 20(5):398-408. PubMed ID: 24091282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversation therapy for aphasia: a qualitative review of the literature.
    Simmons-Mackie N; Savage MC; Worrall L
    Int J Lang Commun Disord; 2014; 49(5):511-26. PubMed ID: 24861277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of an intensive residential aphasia treatment program: rationale, clinical processes, and outcomes.
    Winans-Mitrik RL; Hula WD; Dickey MW; Schumacher JG; Swoyer B; Doyle PJ
    Am J Speech Lang Pathol; 2014 May; 23(2):S330-42. PubMed ID: 24687159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech and language therapy for aphasia following stroke.
    Brady MC; Kelly H; Godwin J; Enderby P; Campbell P
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD000425. PubMed ID: 27245310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, Processes, and Retrospective Outcomes From an Intensive Comprehensive Aphasia Program.
    Babbitt EM; Worrall L; Cherney LR
    Am J Speech Lang Pathol; 2015 Nov; 24(4):S854-63. PubMed ID: 26140692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting a research agenda to inform intensive comprehensive aphasia programs.
    Hula WD; Cherney LR; Worrall LE
    Top Stroke Rehabil; 2013; 20(5):409-20. PubMed ID: 24091283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention control comparisons with SLT for people with aphasia following stroke: methodological concerns raised following a systematic review.
    Brady MC; Godwin J; Kelly H; Enderby P; Elders A; Campbell P
    Clin Rehabil; 2018 Oct; 32(10):1383-1395. PubMed ID: 29911416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
    Breitenstein C; Grewe T; Flöel A; Ziegler W; Springer L; Martus P; Huber W; Willmes K; Ringelstein EB; Haeusler KG; Abel S; Glindemann R; Domahs F; Regenbrecht F; Schlenck KJ; Thomas M; Obrig H; de Langen E; Rocker R; Wigbers F; Rühmkorf C; Hempen I; List J; Baumgaertner A;
    Lancet; 2017 Apr; 389(10078):1528-1538. PubMed ID: 28256356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral interventions for poststroke aphasia.
    Cherney LR; Carpenter J
    Handb Clin Neurol; 2022; 185():197-220. PubMed ID: 35078599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and language therapy for aphasia following stroke.
    Kelly H; Brady MC; Enderby P
    Cochrane Database Syst Rev; 2010 May; (5):CD000425. PubMed ID: 20464716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speech and language therapy for aphasia following stroke.
    Brady MC; Kelly H; Godwin J; Enderby P
    Cochrane Database Syst Rev; 2012 May; (5):CD000425. PubMed ID: 22592672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK speech and language therapists' views and reported practices of discourse analysis in aphasia rehabilitation.
    Cruice M; Botting N; Marshall J; Boyle M; Hersh D; Pritchard M; Dipper L
    Int J Lang Commun Disord; 2020 May; 55(3):417-442. PubMed ID: 32090417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial.
    Baumgaertner A; Grewe T; Ziegler W; Floel A; Springer L; Martus P; Breitenstein C
    Trials; 2013 Sep; 14():308. PubMed ID: 24059983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.